Clarapath
PrivateLast Round
Series B
Extension
Jul 24, 2024
Total Funding Raised
$98M
Company Overview
Clarapath is a medical robotics company that provides integrated robotic solutions to automate and improve the processing of human and animal tissue for pathological analysis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Workflow Automation
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clarapath Comparables
Compare Clarapath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Morphle Labs | 85% | |
| Sakura Finetek USA, Inc. | 78% | |
| Danaher Corporation | 73% | |
Clarapath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 24, 2024 | ||||
| Series B | Nov 18, 2021 | ||||
| Series B | Apr 1, 2021 |
Clarapath Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ochsner Ventures | Series B Extension |
| P5 Health Ventures | Series B |
| Epiphron Capital | Series B |
| Northwell Holdings | Series B, Series B Extension |
| East Post Road Ventures | Series B |
| The 4100 Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Launched SectionStar, the next-generation robotic microtomy platform.
- Nov 18, 2021
$32M round led by Northwell Health.
Clarapath Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Clarapath's valuation, stock price, and market status.